143 related articles for article (PubMed ID: 9698269)
1. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda).
Korten S; Wildenburg G; Darge K; Büttner DW
Acta Trop; 1998 Jun; 70(2):217-31. PubMed ID: 9698269
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin influence on the mast cell activity in nodules of onchocerciasis patients.
Wildenburg G; Korten S; Mainuka P; Büttner DW
Trop Med Int Health; 1998 Nov; 3(11):918-25. PubMed ID: 9855406
[TBL] [Abstract][Full Text] [Related]
3. Mast cell distribution in nodules of Onchocerca volvulus from untreated patients with generalized onchocerciasis.
Wildenburg G; Korten S; Büttner DW
Parasitology; 1998 Mar; 116 ( Pt 3)():257-68. PubMed ID: 9550219
[TBL] [Abstract][Full Text] [Related]
4. Low levels of transforming growth factor-beta (TGF-beta) and reduced suppression of Th2-mediated inflammation in hyperreactive human onchocerciasis.
Korten S; Hoerauf A; Kaifi JT; Büttner DW
Parasitology; 2011 Jan; 138(1):35-45. PubMed ID: 20619070
[TBL] [Abstract][Full Text] [Related]
5. Immunohistology of ectopic secondary lymph follicles in subcutaneous nodules from patients with hyperreactive onchocerciasis (sowda).
Brattig NW; Tenner-Racz K; Korten S; Hoerauf A; Büttner DW
Parasitol Res; 2010 Aug; 107(3):657-66. PubMed ID: 20524133
[TBL] [Abstract][Full Text] [Related]
6. [Human onchocerciasis and "sowda" in the Republic of Yemen].
Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
[TBL] [Abstract][Full Text] [Related]
7. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Darge K; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous onchocercoma.
Okulicz JF; Stibich AS; Elston DM; Schwartz RA
Int J Dermatol; 2004 Mar; 43(3):170-2. PubMed ID: 15009384
[TBL] [Abstract][Full Text] [Related]
9. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
Ali MM; Baraka OZ; AbdelRahman SI; Sulaiman SM; Williams JF; Homeida MM; Mackenzie CD
J Infect Dis; 2003 Feb; 187(4):714-7. PubMed ID: 12599094
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil granule proteins: evidence for the participation in the host reaction to skin microfilariae of Onchocerca volvulus after diethylcarbamazine administration.
Gutiérrez-Peña EJ; Knab J; Büttner DW
Parasitology; 1996 Oct; 113 ( Pt 4)():403-14. PubMed ID: 8873478
[TBL] [Abstract][Full Text] [Related]
11. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda).
Gallin MY; Jacobi AB; Büttner DW; Schönberger O; Marti T; Erttmann KD
J Exp Med; 1995 Jul; 182(1):41-7. PubMed ID: 7790822
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological studies on macrophages in lymph nodes of onchocerciasis patients after treatment with ivermectin.
Knab J; Darge K; Büttner DW
Trop Med Int Health; 1997 Dec; 2(12):1156-69. PubMed ID: 9438472
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
Timmann C; Abraha RS; Hamelmann C; Buttner DW; Lepping B; Marfo Y; Brattig N; Horstmann RD
Br J Dermatol; 2003 Oct; 149(4):782-7. PubMed ID: 14616370
[TBL] [Abstract][Full Text] [Related]
15. The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda).
Hoerauf A; Kruse S; Brattig NW; Heinzmann A; Mueller-Myhsok B; Deichmann KA
Microbes Infect; 2002 Jan; 4(1):37-42. PubMed ID: 11825773
[TBL] [Abstract][Full Text] [Related]
16. Sowda--onchocerciasis in north Yemen: a clinicopathologic study of 18 patients.
Connor DH; Gibson DW; Neafie RC; Merighi B; Buck AA
Am J Trop Med Hyg; 1983 Jan; 32(1):123-37. PubMed ID: 6824118
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta expression by host cells is elicited locally by the filarial nematode Onchocerca volvulus in hyporeactive patients independently from Wolbachia.
Korten S; Kaifi JT; Büttner DW; Hoerauf A
Microbes Infect; 2010 Jul; 12(7):555-64. PubMed ID: 20359544
[TBL] [Abstract][Full Text] [Related]
18. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopical studies on onchocerciasis. II. Skin and microfilariae after treatment with metrifonate.
Burchard GD; Albiez EJ; Bierther M
Tropenmed Parasitol; 1979 Mar; 30(1):97-102. PubMed ID: 375516
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus.
Edgeworth JD; Abiose A; Jones BR
Clin Exp Immunol; 1993 Apr; 92(1):84-92. PubMed ID: 8467568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
